Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
bg-medicine.com

See what CB Insights has to offer

Founded Year

2000

Stage

IPO | IPO

Total Raised

$65.55M

Date of IPO

2/21/2011

Revenue

$0000 

About Bg Medicine

Bg Medicine is developing transformative in vitro and in vivo diagnostic products. BG Medicine is a life sciences company focused on the discovery, development, and commercialization of novel diagnostic tests based on biomarkers for high-value market opportunities in healthcare.Bg Medicine is developing multiple product candidates for cardiac and other diseases and have recently begun limited sales and marketing activities in Europe for the company's lead product, BGM Galectin-3. The company believe that its tests will provide clinicians with improved information to better detect and characterize disease states and that this improved information may enable physicians to achieve better patient outcomes and contain healthcare costs through:Earlier diagnosis,Segmentation based on underlying disease processes,More accurate prognosis, andPersonalized treatment selection or monitoring of disease based on disease activity.Bg Medicine's focus is on blood-based tests due to the ease and low cost of access to evaluable samples for testing and the opportunity for repeat sampling to monitor changes in a patient's medical condition.

Bg Medicine Headquarter Location

610 Lincoln Street North

Waltham, Massachusetts, 02451,

United States

781-890-1199

Latest Bg Medicine News

Cardiac Marker Testing Market (COVID – 19 Updates) 2020 to See Stunning Growth Worldwide, Leading Players -Siemens Healthcare Private Limited, Danaher, bioMérieux, Inc., Ortho Clinical Diagnostics, Randox Laboratories Ltd, BG Medicine, Inc., HUMAN

Sep 17, 2020

Search jobs 17-Sep-2020 Cardiac Marker Testing Market (COVID – 19 Updates) 2020 to See Stunning Growth Worldwide, Leading Players -Siemens Healthcare Private Limited, Danaher, bioMérieux, Inc., Ortho Clinical Diagnostics, Randox Laboratories Ltd, BG Medicine, Inc., HUMAN This Cardiac Marker Testing Market research report offers an array of insights about industry and business solutions that will support to stay ahead of the competition. A systematic investment analysis is also underlined in this report which forecasts impending opportunities for the market players. The market report is an outcome of persistent and numerous efforts lead by knowledgeable forecasters, innovative analysts and brilliant researchers who carry out detailed and diligent research on different markets, trends and emerging opportunities in the consecutive direction for the business needs. The credible Cardiac Marker Testing Market report provides company profiling of key players in the industry, carefully analyzing their core competencies, and drawing a competitive landscape for the market. The data involved in this market report can be very necessary when it comes to dominating the market or making a mark in the market as a new emergent. To generate the best market research report, a range of objectives of the marketing research are required to be kept in mind. Market research analysis and data lend a hand to businesses for the planning of production, product launches, costing, inventory, purchasing and marketing strategies. Cardiac marker testing market  is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to grow at a CAGR of 9.1% in the above-mentioned forecast period. Increasing demand for point of care testing with cardiac biomarkers is expected to create new opportunity for the market. Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cardiac-marker-testing-market The major players covered in the cardiac marker testing market report are F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthcare Private Limited, Danaher, bioMérieux, Inc., Ortho Clinical Diagnostics, Randox Laboratories Ltd, BG Medicine, Inc., HUMAN, Bhat Bio-tech India Private Limited, DIALAB GmbH, Beckman Coulter, Inc, among other domestic and global players. Market share and data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. Global Cardiac Marker Testing Market By Type (Troponin I and T, CK-MB, BNP Or NT-PROBNP, Myoglobin, HSCRP, Other Biomarkers), Product (Instruments, Chemiluminescence, Immunofluorescence, ELISA, Immunochromatography, Reagents and Kits), Disease (Myocardial Infarction, Congestive Heart Failure), Type of Testing (Laboratory Testing, Point-Of-Care Testing), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027 Cardiac markers are used in patients with chest pain and presumed coronary acute syndrome (ACS) treatment and risk stratification. Some of the common types of the cardiac marker testing are Troponin I & T, HDCRP, myoglobin, CK- MB and others. Increasing prevalence of cardiovascular diseases is expected to enhance the market growth. Some of the other factors such as rising aging population, rising hear diseases, increasing clinical trials for the identification of cardiac biomarkers and growing funding from public–private organizations for research on cardiac biomarkers is also expected to drive the cardiac marker testing market in the forecast period of 2020 to 2027. Increasing problems associated with the sample collection & storage and complexity associated with the reimbursement system will also restrain the market growth in the mentioned forecast. Global Cardiac Marker Testing Market Scope and Market Size Cardiac marker testing market is segmented of the basis of type, product, disease and type of testing. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. On the basis of type, the cardiac marker testing market is segmented into Troponin I and T, CK-MB, BNP or NT-PROBNP, Myoglobin, HSCRP and other biomarkers. Based on product, the cardiac marker testing market is segmented into Instruments, Chemiluminescence, Immunofluorescence, ELISA, Immunochromatography, Reagents and Kits. Type of testing segment is divided into laboratory testing and point-of-care testing. Based on disease, the cardiac marker testing market is segmented into myocardial infarction and congestive heart failure. Grab Your Report at an Impressive 30% Discount! Please click Here @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cardiac-marker-testing-market Table of Contents: Healthcare Infrastructure Growth Installed base and New Technology Penetration Cardiac marker testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for cardiac marker testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cardiac marker testing market. The data is available for historic period 2010 to 2018. Competitive Landscape and Cardiac Marker Testing Market Share Analysis Cardiac marker testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to cardiac marker testing market. Note: If you have any special requirements, please let us know and we will offer you the report as you want. About Data Bridge Market Research: Data Bridge Market Research  set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Bg Medicine Patents

Bg Medicine has filed 8 patents.

The 3 most popular patent topics include:

  • Cardiac arrhythmia
  • Cardiology
  • Cardiovascular physiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/15/2010

3/1/2016

Cardiology, Heart diseases, Nutrition, Ischemic heart diseases, Lipid disorders

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/15/2010

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/1/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Cardiology, Heart diseases, Nutrition, Ischemic heart diseases, Lipid disorders

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Bg Medicine Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Bg Medicine Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.